Literature DB >> 31583567

A novel IRF2BPL truncating variant is associated with endolysosomal storage.

Monia Ginevrino1,2, Roberta Battini3,4, Sara Nuovo1,5, Alessandro Simonati6, Alessia Micalizzi7, Ilaria Contaldo8, Valentina Serpieri2, Enza Maria Valente9,10.   

Abstract

De novo mutations in the IRF2BPL gene have been identified to date in 18 patients presenting with neuromotor regression, epilepsy and variable neurological signs. Here, we report a female child carrying a novel heterozygous truncating variant in IRF2BPL. Following normal development for two and half years, she developed a progressive neurological condition with psychomotor regression, dystonic tetraparesis with hyperkinetic movements, but no overt epilepsy. Skin biopsy revealed enlarged lysosomes containing granular and tubular material, suggestive of a lysosomal storage disorder. This case expands the IRF2BPL phenotypic spectrum, for the first time providing evidence of endolysosomal storage.

Entities:  

Keywords:  De novo mutations; IRF2BPL; Lysosomal storage disorders; Neurodegenerative disorders; Neuronal ceroid lipofuscinosis

Mesh:

Substances:

Year:  2019        PMID: 31583567     DOI: 10.1007/s11033-019-05109-7

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  12 in total

1.  Characterization of C14orf4, a novel intronless human gene containing a polyglutamine repeat, mapped to the ARVD1 critical region.

Authors:  A Rampazzo; F Pivotto; G Occhi; N Tiso; S Bortoluzzi; L Rowen; L Hood; A Nava; G A Danieli
Journal:  Biochem Biophys Res Commun       Date:  2000-11-30       Impact factor: 3.575

2.  The human intronless melanocortin 4-receptor gene is NMD insensitive.

Authors:  Katja S Brocke; Gabriele Neu-Yilik; Niels H Gehring; Matthias W Hentze; Andreas E Kulozik
Journal:  Hum Mol Genet       Date:  2002-02-01       Impact factor: 6.150

3.  A homozygous mutation in KCTD7 links neuronal ceroid lipofuscinosis to the ubiquitin-proteasome system.

Authors:  John F Staropoli; Amel Karaa; Elaine T Lim; Andrew Kirby; Naser Elbalalesy; Stephen G Romansky; Karen B Leydiker; Scott H Coppel; Rosemary Barone; Winnie Xin; Marcy E MacDonald; Jose E Abdenur; Mark J Daly; Katherine B Sims; Susan L Cotman
Journal:  Am J Hum Genet       Date:  2012-06-28       Impact factor: 11.025

4.  IRF2BPL Is Associated with Neurological Phenotypes.

Authors:  Paul C Marcogliese; Vandana Shashi; Rebecca C Spillmann; Nicholas Stong; Jill A Rosenfeld; Mary Kay Koenig; Julián A Martínez-Agosto; Matthew Herzog; Agnes H Chen; Patricia I Dickson; Henry J Lin; Moin U Vera; Noriko Salamon; John M Graham; Damara Ortiz; Elena Infante; Wouter Steyaert; Bart Dermaut; Bruce Poppe; Hyung-Lok Chung; Zhongyuan Zuo; Pei-Tseng Lee; Oguz Kanca; Fan Xia; Yaping Yang; Edward C Smith; Joan Jasien; Sujay Kansagra; Gail Spiridigliozzi; Mays El-Dairi; Robert Lark; Kacie Riley; Dwight D Koeberl; Katie Golden-Grant; Shinya Yamamoto; Michael F Wangler; Ghayda Mirzaa; Dimitri Hemelsoet; Brendan Lee; Stanley F Nelson; David B Goldstein; Hugo J Bellen; Loren D M Pena
Journal:  Am J Hum Genet       Date:  2018-07-26       Impact factor: 11.025

5.  Forkhead Box F2 Suppresses Gastric Cancer through a Novel FOXF2-IRF2BPL-β-Catenin Signaling Axis.

Authors:  Akira Higashimori; Yujuan Dong; Yanquan Zhang; Wei Kang; Geicho Nakatsu; Simon S M Ng; Tetsuo Arakawa; Joseph J Y Sung; Francis K L Chan; Jun Yu
Journal:  Cancer Res       Date:  2018-01-26       Impact factor: 12.701

Review 6.  Human pathology in NCL.

Authors:  Glenn W Anderson; Hans H Goebel; Alessandro Simonati
Journal:  Biochim Biophys Acta       Date:  2012-11-29

7.  Preventing dangerous nonsense: selection for robustness to transcriptional error in human genes.

Authors:  Brian P Cusack; Peter F Arndt; Laurent Duret; Hugues Roest Crollius
Journal:  PLoS Genet       Date:  2011-10-13       Impact factor: 5.917

Review 8.  Dysregulation of Ubiquitin-Proteasome System in Neurodegenerative Diseases.

Authors:  Qiuyang Zheng; Timothy Huang; Lishan Zhang; Ying Zhou; Hong Luo; Huaxi Xu; Xin Wang
Journal:  Front Aging Neurosci       Date:  2016-12-15       Impact factor: 5.750

Review 9.  Dysregulation of autophagy as a common mechanism in lysosomal storage diseases.

Authors:  Elena Seranova; Kyle J Connolly; Malgorzata Zatyka; Tatiana R Rosenstock; Timothy Barrett; Richard I Tuxworth; Sovan Sarkar
Journal:  Essays Biochem       Date:  2017-12-12       Impact factor: 8.000

10.  Homozygous TBC1 domain-containing kinase (TBCK) mutation causes a novel lysosomal storage disease - a new type of neuronal ceroid lipofuscinosis (CLN15)?

Authors:  Stefanie Beck-Wödl; Klaus Harzer; Marc Sturm; Rebecca Buchert; Olaf Rieß; Hans-Dieter Mennel; Elisabeth Latta; Axel Pagenstecher; Ursula Keber
Journal:  Acta Neuropathol Commun       Date:  2018-12-27       Impact factor: 7.801

View more
  4 in total

Review 1.  Genetic Dystonias: Update on Classification and New Genetic Discoveries.

Authors:  Ignacio Juan Keller Sarmiento; Niccolò Emanuele Mencacci
Journal:  Curr Neurol Neurosci Rep       Date:  2021-02-09       Impact factor: 5.081

Review 2.  Emerging and converging molecular mechanisms in dystonia.

Authors:  Paulina Gonzalez-Latapi; Nicolas Marotta; Niccolò E Mencacci
Journal:  J Neural Transm (Vienna)       Date:  2021-01-01       Impact factor: 3.575

Review 3.  The apparent paradox of phenotypic diversity and shared mechanisms across dystonia syndromes.

Authors:  Alessio Di Fonzo; Alberto Albanese; Hyder A Jinnah
Journal:  Curr Opin Neurol       Date:  2022-07-05       Impact factor: 6.283

4.  Loss of IRF2BPL impairs neuronal maintenance through excess Wnt signaling.

Authors:  Paul C Marcogliese; Debdeep Dutta; Shrestha Sinha Ray; Nghi D P Dang; Zhongyuan Zuo; Yuchun Wang; Di Lu; Fatima Fazal; Thomas A Ravenscroft; Hyunglok Chung; Oguz Kanca; JiJun Wan; Emilie D Douine; Undiagnosed Diseases Network; Loren D M Pena; Shinya Yamamoto; Stanley F Nelson; Matthew Might; Kathrin C Meyer; Nan Cher Yeo; Hugo J Bellen
Journal:  Sci Adv       Date:  2022-01-19       Impact factor: 14.136

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.